Alterity Therapeutics (ATHE) Change in Receivables (2009 - 2020)

Alterity Therapeutics' Change in Receivables history runs 9 years deep, the most recent figure standing at $898621.0 for Q2 2020.

• In Q2 2020, Change in Receivables rose 176.49% year-over-year to $898621.0; the TTM figure through Jun 2020 stood at -$542814.8 (up 15.57% YoY), while the FY2025 annual figure was $66648.6, down 97.81% from the prior year.
• Change in Receivables was $898621.0 for Q2 2020 at Alterity Therapeutics, up from -$2.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $1.7 million in Q4 2018 to a low of -$2.2 million in Q4 2016.
• Historically, Change in Receivables has averaged -$150911.9 across 5 years, with a median of -$884.5 in 2018.
• The sharpest annual moves came in 2018 and 2019: Change in Receivables surged 243.82% in 2018, then sank 132715.6% in 2019.
• A 5-year view of Change in Receivables shows it stood at -$2.2 million in 2016, then soared by 44.88% to -$1.2 million in 2017, then soared by 243.82% to $1.7 million in 2018, then sank by 215.25% to -$2.0 million in 2019, then soared by 144.59% to $898621.0 in 2020.
• The last three Change in Receivables figures came in at $898621.0 (Q2 2020), -$2.0 million (Q4 2019), and -$1.2 million (Q2 2019), per Business Quant data.